<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34541421</PMID><DateRevised><Year>2024</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">2452-302X</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><Issue>9</Issue><PubDate><Year>2021</Year><Season>Sep-Oct</Season></PubDate></JournalIssue><Title>JACC. Basic to translational science</Title><ISOAbbreviation>JACC Basic Transl Sci</ISOAbbreviation></Journal><ArticleTitle>Postacute Sequelae of Severe Acute&#xa0;Respiratory Syndrome Coronavirus&#xa0;2 Infection: A State-of-the-Art Review.</ArticleTitle><Pagination><StartPage>796</StartPage><EndPage>811</EndPage><MedlinePgn>796-811</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jacbts.2021.07.002</ELocationID><Abstract><AbstractText>The vast majority of patients (&gt;99%) with severe acute respiratory syndrome coronavirus 2 survive immediate infection but remain at risk for persistent and/or delayed multisystem. This review of published reports through May 31, 2021, found that manifestations of postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection (PASC) affect between 33% and 98% of coronavirus disease 2019 survivors and comprise a wide range of symptoms and complications in the pulmonary, cardiovascular, neurologic, psychiatric, gastrointestinal, renal, endocrine, and musculoskeletal systems in both adult and pediatric populations. Additional complications are likely to emerge and be identified over time. Although data on PASC risk factors and vulnerable populations are scarce, evidence points to a disproportionate impact on racial/ethnic minorities, older patients, patients with preexisting conditions, and rural residents. Concerted efforts by researchers, health systems, public health agencies, payers, and governments are urgently needed to better understand and mitigate the long-term effects of PASC on individual and population health.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>David H</ForeName><Initials>DH</Initials><AffiliationInfo><Affiliation>Division of Health Care Delivery and Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Roy</LastName><ForeName>Darius J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Division of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Brett J</ForeName><Initials>BJ</Initials><AffiliationInfo><Affiliation>School of Medicine, Yale University; New Haven, Connecticut, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassett</LastName><ForeName>Leslie C</ForeName><Initials>LC</Initials><AffiliationInfo><Affiliation>Mayo Clinic Library, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McCoy</LastName><ForeName>Rozalina G</ForeName><Initials>RG</Initials><AffiliationInfo><Affiliation>Division of Health Care Delivery and Research, Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Community Internal Medicine, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>09</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>JACC Basic Transl Sci</MedlineTA><NlmUniqueID>101677259</NlmUniqueID><ISSNLinking>2452-302X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ACE2, angiotensin-converting enzyme 2</Keyword><Keyword MajorTopicYN="N">AKI, acute kidney injury</Keyword><Keyword MajorTopicYN="N">COVID-19, coronavirus disease-2019</Keyword><Keyword MajorTopicYN="N">PASC, postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection</Keyword><Keyword MajorTopicYN="N">PIMS, pediatric inflammatory multisystem syndrome</Keyword><Keyword MajorTopicYN="N">POTS, postural tachycardia syndrome</Keyword><Keyword MajorTopicYN="N">RRT, renal replacement therapy</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2, severe acute respiratory syndrome-coronavirus-2</Keyword><Keyword MajorTopicYN="N">coronavirus disease 2019</Keyword><Keyword MajorTopicYN="N">disparities</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">postacute sequelae of severe acute respiratory syndrome coronavirus 2 infection</Keyword><Keyword MajorTopicYN="N">vulnerable population</Keyword></KeywordList><CoiStatement>This effort was funded by the National Institute of Health, National Institute of Diabetes and Digestive and Kidney Diseases (grant K23DK114497 [Dr McCoy]) and the Mayo Clinic Research Pipeline K2R Program Award (Dr McCoy). Study contents are the sole responsibility of the authors and do not necessarily represent the official views of National Institutes of Health. Dr McCoy has received support from the National Institute of Diabetes and Digestive and Kidney Diseases (grants R03DK127010 and P30DK11024) and AARP (Quality Measure Innovation Grant) in the past 36&#xa0;months. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>6</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>9</Month><Day>21</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>9</Month><Day>20</Day><Hour>6</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>9</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34541421</ArticleId><ArticleId IdType="pmc">PMC8442719</ArticleId><ArticleId IdType="doi">10.1016/j.jacbts.2021.07.002</ArticleId><ArticleId IdType="pii">S2452-302X(21)00234-5</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>COVID-19 United States cases by county. Coronavirus Resources Center. Johns Hopkins University; 2021. https://coronavirus.jhu.edu/ Accessed June 18, 2021.</Citation></Reference><Reference><Citation>Bosman J, Smith M. Covid-19: U.S. vaccinations increase, but virus continues to spread. New York Times. July 2, 2021. Accessed July 22, 2021. https://www.nytimes.com/live/2021/03/19/world/covid-vaccine-coronavirus-cases</Citation></Reference><Reference><Citation>Borchering R.K., Viboud C., Howerton E. Modeling of future COVID-19 cases, hospitalizations, and deaths, by vaccination rates and nonpharmaceutical intervention scenarios&#x2014;United States, April-September 2021. MMWR Morb Mortal Wkly Rep. 2021;70(19):719&#x2013;724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8118153</ArticleId><ArticleId IdType="pubmed">33988185</ArticleId></ArticleIdList></Reference><Reference><Citation>Ioannidis J.P.A. Infection fatality rate of COVID-19 inferred from seroprevalence data. Bull World Health Organ. 2021;99(1):19&#x2013;33f.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7947934</ArticleId><ArticleId IdType="pubmed">33716331</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A.V., Jayadevan R., Sashidharan S. Long COVID: an overview. Diabetes Metab Syndr. 2021;15(3):869&#x2013;875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8056514</ArticleId><ArticleId IdType="pubmed">33892403</ArticleId></ArticleIdList></Reference><Reference><Citation>Collins F.S. NIH launches new initiative to study &#x201c;Long COVID.&#x201d; February 23, 2021. https://www.nih.gov/about-nih/who-we-are/nih-director/statements/nih-launches-new-initiative-study-long-covid Accessed May 1, 2021.</Citation></Reference><Reference><Citation>Sudre C.H., Murray B., Varsavsky T. Attributes and predictors of long COVID. Nat Med. 2021;27(4):626&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7611399</ArticleId><ArticleId IdType="pubmed">33692530</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F., Gemelli Against COVID-19 Post-Acute Care Study Group Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Huang L., Wang Y. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Chopra V., Flanders S.A., O'Malley M., Malani A.N., Prescott H.C. Sixty-day outcomes among patients hospitalized with COVID-19. Ann Intern Med. 2021;174(4):576&#x2013;578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7707210</ArticleId><ArticleId IdType="pubmed">33175566</ArticleId></ArticleIdList></Reference><Reference><Citation>Menni C., Valdes A.M., Freidin M.B. Real-time tracking of self-reported symptoms to predict potential COVID-19. Nat Med. 2020;26(7):1037&#x2013;1040.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751267</ArticleId><ArticleId IdType="pubmed">32393804</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Q., Xu M., Li J. Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 2021;27(1):89&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7510771</ArticleId><ArticleId IdType="pubmed">32979574</ArticleId></ArticleIdList></Reference><Reference><Citation>Halpin S.J., McIvor C., Whyatt G. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation. J&#xa0;Med Virol. 2021;93(2):1013&#x2013;1022.</Citation><ArticleIdList><ArticleId IdType="pubmed">32729939</ArticleId></ArticleIdList></Reference><Reference><Citation>Dennis A., Wamil M., Alberts J. Multiorgan impairment in low-risk individuals with post-COVID-19 syndrome: a prospective, community-based study. BMJ Open. 2021;11(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727683</ArticleId><ArticleId IdType="pubmed">33785495</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Preprint. Posted online March 1, 2021. Res Sq. 2021;rs.3:rs-266574. doi: 10.21023/rs.3.rs-266574/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21023/rs.3.rs-266574/v1</ArticleId><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K., Montenegro-Jim&#xe9;nez Y., Torres-Castro R. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Chron Respir Dis. 2021;18</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Nehme M., Braillard O., Alcoba G., COVICARE Team COVID-19 symptoms: longitudinal evolution and persistence in outpatient settings. Ann Intern Med. 2021;174(5):723&#x2013;725.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7741180</ArticleId><ArticleId IdType="pubmed">33284676</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S., Barnett J., Brill S.E. 'Long-COVID': a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2013;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Logue J.K., Franko N.M., McCulloch D.J. Sequelae in adults at 6&#xa0;months after COVID-19 infection. JAMA Netw Open. 2021;4(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7896197</ArticleId><ArticleId IdType="pubmed">33606031</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Brutto O.H., Wu S., Mera R.M., Costa A.F., Recalde B.Y., Issa N.P. Cognitive decline among individuals with history of mild symptomatic SARS-CoV-2 infection: a longitudinal prospective study nested to a population cohort. Eur J Neurol. 2021;28:3245&#x2013;3253.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8014083</ArticleId><ArticleId IdType="pubmed">33576150</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D., Zhang W., Pan F. The pulmonary sequalae in discharged patients with COVID-19: a short-term observational study. Respir Res. 2020;21(1):125.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7245637</ArticleId><ArticleId IdType="pubmed">32448391</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y.-M., Shang Y.-M., Song W.-B. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7361108</ArticleId><ArticleId IdType="pubmed">32838236</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah A.S., Wong A.W., Hague C.J. A&#xa0;prospective study of 12-week respiratory outcomes in COVID-19-related hospitalisations. Thorax. 2021;76(4):402&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pubmed">33273023</ArticleId></ArticleIdList></Reference><Reference><Citation>Crameri G.A.G., Bielecki M., Zust R., Buehrer T.W., Stanga Z., Deuel J.W. Reduced maximal aerobic capacity after COVID-19 in young adult recruits, Switzerland, May 2020. Euro Surveill. 2020;25(36):2001542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7502899</ArticleId><ArticleId IdType="pubmed">32914744</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv D., Chen X., Wang X. Pulmonary function of patients with 2019 novel coronavirus induced-pneumonia: a retrospective cohort study. Ann Palliat Med. 2020;9:3447&#x2013;3452.</Citation><ArticleIdList><ArticleId IdType="pubmed">33065795</ArticleId></ArticleIdList></Reference><Reference><Citation>Frija-Masson J., Debray M.-P., Gilbert M. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur Respir J. 2020;56(2):2001754.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7301832</ArticleId><ArticleId IdType="pubmed">32554533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nie S., Han S., Ouyang H., Zhang Z. Coronavirus disease 2019-related dyspnea cases difficult to interpret using chest computed tomography. Respir Med. 2020;167:105951.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7195086</ArticleId><ArticleId IdType="pubmed">32421539</ArticleId></ArticleIdList></Reference><Reference><Citation>Daher A., Balfanz P., Cornelissen C. Follow up of patients with severe coronavirus disease 2019 (COVID-19): pulmonary and extrapulmonary disease sequelae. Respir Med. 2020;174:106197.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7573668</ArticleId><ArticleId IdType="pubmed">33120193</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogliani P., Calzetta L., Coppola A. Are there pulmonary sequelae in patients recovering from COVID-19? Respir Res. 2020;21(1):286.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598236</ArticleId><ArticleId IdType="pubmed">33126869</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A&#x2019;Court C., Buxton M., Husain L. Management of postacute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L.L., Yang T. Pulmonary rehabilitation for patients with coronavirus disease 2019 (COVID-19) Chronic Dis Transl Med. 2020;6(2):79&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7221406</ArticleId><ArticleId IdType="pubmed">32411496</ArticleId></ArticleIdList></Reference><Reference><Citation>Becker R.C. Anticipating the long-term cardiovascular effects of COVID-19. J&#xa0;Thromb Thrombolysis. 2020;50(3):512&#x2013;524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7467860</ArticleId><ArticleId IdType="pubmed">32880795</ArticleId></ArticleIdList></Reference><Reference><Citation>Puntmann V.O., Carerj M.L., Wieters I. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19) JAMA Cardiol. 2020;5(11):1265&#x2013;1273.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385689</ArticleId><ArticleId IdType="pubmed">32730619</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang L., Zhao P., Tang D. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. J&#xa0;Am Coll Cardiol Img. 2020;13(11):2330&#x2013;2339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7214335</ArticleId><ArticleId IdType="pubmed">32763118</ArticleId></ArticleIdList></Reference><Reference><Citation>Joy G., Artico J., Kurdi H. Prospective case-control study of cardiovascular abnormalities 6&#xa0;months following mild COVID-19 in healthcare workers. J&#xa0;Am Coll Cardiol Img. Published online May 5, 2021 doi: 10.1016/j.jcmg.2021.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcmg.2021.04.011</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez M.W., Tucker A.M., Bloom O.J. Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol. 2021;6(7):745&#x2013;752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7934073</ArticleId><ArticleId IdType="pubmed">33662103</ArticleId></ArticleIdList></Reference><Reference><Citation>Starekova J., Bluemke D.A., Bradham W.S. Evaluation for myocarditis in competitive student athletes recovering from coronavirus disease 2019 with cardiac magnetic resonance imaging. JAMA Cardiol. 2021;6:945&#x2013;950.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7809616</ArticleId><ArticleId IdType="pubmed">33443537</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark D.E., Parikh A., Dendy J.M. COVID-19 Myocardial Pathology Evaluation in Athletes With Cardiac Magnetic Resonance (COMPETE CMR) Circulation. 2021;143(6):609&#x2013;612.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7864610</ArticleId><ArticleId IdType="pubmed">33332151</ArticleId></ArticleIdList></Reference><Reference><Citation>Sardari A., Tabarsi P., Borhany H., Mohiaddin R., Houshmand G. Myocarditis detected after COVID-19 recovery. Eur Heart J Cardiovasc Imaging. 2021;22(1):131&#x2013;132.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7574602</ArticleId><ArticleId IdType="pubmed">32462177</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott N., Martin R., Heron N., Elliott J., Grimstead D., Biswas A. Infographic. Graduated return to play guidance following COVID-19 infection. Br J Sports Med. 2020;54(19):1174&#x2013;1175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7371566</ArticleId><ArticleId IdType="pubmed">32571796</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzl J.D., McElheny K., Robinson J.N., Scott D.A., Sutton K.M., Toresdahl B.G. Considerations for return to exercise following mild-to-moderate COVID-19 in the recreational athlete. HSS J. 2020;16(suppl 1):1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7416806</ArticleId><ArticleId IdType="pubmed">32837412</ArticleId></ArticleIdList></Reference><Reference><Citation>Phelan D., Kim J.H., Elliott M.D. Screening of potential cardiac involvement in competitive athletes recovering from COVID-19: an expert consensus statement. J&#xa0;Am Coll Cardiol Img. 2020;13(12):2635&#x2013;2652.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598679</ArticleId><ArticleId IdType="pubmed">33303102</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.H., Levine B.D., Phelan D. Coronavirus disease 2019 and the athletic heart: emerging perspectives on pathology, risks, and return to play. JAMA Cardiol. 2021;6(2):219&#x2013;227.</Citation><ArticleIdList><ArticleId IdType="pubmed">33104154</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein D.S. The possible association between COVID-19 and postural tachycardia syndrome. Heart Rhythm. 2021;18(4):508&#x2013;509.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7729277</ArticleId><ArticleId IdType="pubmed">33316414</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanjwal K., Jamal S., Kichloo A., Grubb B.P. New-onset postural orthostatic tachycardia syndrome following coronavirus disease 2019 infection. J&#xa0;Innov Card Rhythm Manag. 2020;11(11):4302&#x2013;4304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7685310</ArticleId><ArticleId IdType="pubmed">33262898</ArticleId></ArticleIdList></Reference><Reference><Citation>Miglis M.G., Prieto T., Shaik R., Muppidi S., Sinn D.-I., Jaradeh S. A&#xa0;case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020;30(5):449&#x2013;451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471493</ArticleId><ArticleId IdType="pubmed">32880754</ArticleId></ArticleIdList></Reference><Reference><Citation>Umapathi T., Poh M.Q.W., Fan B.E., Li K.F.C., George J., Tan J.Y.L. Acute hyperhidrosis and postural tachycardia in a COVID-19 patient. Clin Auton Res. 2020;30(6):571&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7511524</ArticleId><ArticleId IdType="pubmed">32970212</ArticleId></ArticleIdList></Reference><Reference><Citation>Qureshi A.I., Baskett W.I., Huang W. Acute ischemic stroke and COVID-19. Stroke. 2021;52(3):905&#x2013;912.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7903982</ArticleId><ArticleId IdType="pubmed">33535779</ArticleId></ArticleIdList></Reference><Reference><Citation>Nannoni S., de Groot R., Bell S., Markus H.S. Stroke in COVID-19: a systematic review and meta-analysis. Int J Stroke. 2021;16(2):137&#x2013;149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7859578</ArticleId><ArticleId IdType="pubmed">33103610</ArticleId></ArticleIdList></Reference><Reference><Citation>Modin D., Claggett B., Sindet-Pedersen C. Acute COVID-19 and the incidence of ischemic stroke and acute myocardial infarction. Circulation. 2020;142(21):2080&#x2013;2082.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682795</ArticleId><ArticleId IdType="pubmed">33054349</ArticleId></ArticleIdList></Reference><Reference><Citation>Mao L., Jin H., Wang M. Neurologic manifestations of hospitalized patients with coronavirus disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683&#x2013;690.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7149362</ArticleId><ArticleId IdType="pubmed">32275288</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R., Bogue T., Koshy A. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020;136(1):1342&#x2013;1346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts L.N., Whyte M.B., Georgiou L. Postdischarge venous thromboembolism following hospital admission with COVID-19. Blood. 2020;136(11):1347&#x2013;1350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7483432</ArticleId><ArticleId IdType="pubmed">32746455</ArticleId></ArticleIdList></Reference><Reference><Citation>Paderno A., Schreiber A., Grammatica A. Smell and taste alterations in COVID-19: a cross-sectional analysis of different cohorts. Int Forum Allergy Rhinol. 2020;10(8):955&#x2013;962.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272886</ArticleId><ArticleId IdType="pubmed">32410386</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitcroft K.L., Hummel T. Olfactory dysfunction in COVID-19: diagnosis and management. JAMA. 2020;323(24):2512&#x2013;2514.</Citation><ArticleIdList><ArticleId IdType="pubmed">32432682</ArticleId></ArticleIdList></Reference><Reference><Citation>Vaira L.A., Hopkins C., Petrocelli M. Smell and taste recovery in coronavirus disease 2019 patients: a 60-day objective and prospective study. J&#xa0;Laryngol Otol. 2020;134(8):703&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7471571</ArticleId><ArticleId IdType="pubmed">32782030</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong J.Y., Wong A., Zhu D., Fastenberg J.H., Tham T. The prevalence of olfactory and gustatory dysfunction in COVID-19 patients: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2020;163(1):3&#x2013;11.</Citation><ArticleIdList><ArticleId IdType="pubmed">32369429</ArticleId></ArticleIdList></Reference><Reference><Citation>Panda S., Mohamed A., Sikka K. Otolaryngologic manifestation and long-term outcome in mild COVID-19: experience from a tertiary care centre in India. Indian J Otolaryngol Head Neck Surg. 2020;73(1):1&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556593</ArticleId><ArticleId IdType="pubmed">33078125</ArticleId></ArticleIdList></Reference><Reference><Citation>Meini S., Suardi L.R., Busoni M., Roberts A.T., Fortini A. Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life. Eur Arch Otorhinolaryngol. 2020;277:3519&#x2013;3523.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271634</ArticleId><ArticleId IdType="pubmed">32500326</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho D.H., Kons Z.A., Costanzo R.M., Reiter E.R. Subjective changes in smell and taste during the COVID-19 pandemic: a national survey-preliminary results. Otolaryngol Head Neck Surg. 2020;163(2):302&#x2013;306.</Citation><ArticleIdList><ArticleId IdType="pubmed">32423359</ArticleId></ArticleIdList></Reference><Reference><Citation>Reiter E.R., Coelho D.H., Kons Z.A., Costanzo R.M. Subjective smell and taste changes during the COVID-19 pandemic: short term recovery. Am J Otolaryngol. 2020;41(6):102639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7341046</ArticleId><ArticleId IdType="pubmed">32682192</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan C.H., Prajapati D.P., Ritter M.L., DeConde A.S. Persistent smell loss following undetectable SARS-CoV-2. Otolaryngol Head Neck Surg. 2020;163(5):923&#x2013;925.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8809452</ArticleId><ArticleId IdType="pubmed">32513065</ArticleId></ArticleIdList></Reference><Reference><Citation>Lv H., Zhang W., Zhu Z. Prevalence and recovery time of olfactory and gustatory dysfunction in hospitalized patients with COVID-19 in Wuhan, China. Int J Infect Dis. 2020;100:507&#x2013;512.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7497396</ArticleId><ArticleId IdType="pubmed">32950734</ArticleId></ArticleIdList></Reference><Reference><Citation>Forster P., Forster L., Renfrew C., Forster M. Phylogenetic network analysis of SARS-CoV-2 genomes. Proc Natl Acad Sci U S A. 2020;117(17):9241&#x2013;9243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7196762</ArticleId><ArticleId IdType="pubmed">32269081</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y., Li L., Feng Z. Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations. Cell Discov. 2020;6:11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7040011</ArticleId><ArticleId IdType="pubmed">32133153</ArticleId></ArticleIdList></Reference><Reference><Citation>Heilmann S., Huettenbrink K.B., Hummel T. Local and systemic administration of corticosteroids in the treatment of olfactory loss. Am J Rhinol. 2004;18(1):29&#x2013;33.</Citation><ArticleIdList><ArticleId IdType="pubmed">15035568</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorokowska A., Drechsler E., Karwowski M., Hummel T. Effects of olfactory training: a meta-analysis. Rhinology. 2017;55(1):17&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">28040824</ArticleId></ArticleIdList></Reference><Reference><Citation>Munro K.J., Uus K., Almufarrij I., Chaudhuri N., Yioe V. Persistent self-reported changes in hearing and tinnitus in post-hospitalisation COVID-19 cases. Int J Audiol. 2020;59(12):889&#x2013;890.</Citation><ArticleIdList><ArticleId IdType="pubmed">32735466</ArticleId></ArticleIdList></Reference><Reference><Citation>Abrishami M., Emamverdian Z., Shoeibi N. Optical coherence tomography angiography analysis of the retina in patients recovered from COVID-19: a case-control study. Can J Ophthalmol. 2021;56(1):24&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666612</ArticleId><ArticleId IdType="pubmed">33249111</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Tanaka T., Narazaki M., Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harb Perspect Biol. 2014;6(10):a016295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4176007</ArticleId><ArticleId IdType="pubmed">25190079</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang C., Wu Z., Li J.W., Zhao H., Wang G.Q. Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality. Int J Antimicrob Agents. 2020;55(5):105954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118634</ArticleId><ArticleId IdType="pubmed">32234467</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Alessandro A., Thomas T., Dzieciatkowska M. Serum proteomics in COVID-19 patients: altered coagulation and complement status as a function of IL-6 level. J&#xa0;Proteome Res. 2020;19(11):4417&#x2013;4427.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640953</ArticleId><ArticleId IdType="pubmed">32786691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y.Q., Liu Z., Liu Z.H. Interleukin-6: an emerging regulator of pathological pain. J&#xa0;Neuroinflammation. 2016;13(1):141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4897919</ArticleId><ArticleId IdType="pubmed">27267059</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarchielli P., Alberti A., Baldi A. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache. 2006;46(2):200&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">16492228</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J.S., Adwanikar H., Li Z., Ji G., Neugebauer V. Facilitation of synaptic transmission and pain responses by CGRP in the amygdala of normal rats. Mol Pain. 2010;6:10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2829526</ArticleId><ArticleId IdType="pubmed">20144185</ArticleId></ArticleIdList></Reference><Reference><Citation>Caronna E., Ballve A., Llaurado A. Headache: a striking prodromal and persistent symptom, predictive of COVID-19 clinical evolution. Cephalalgia. 2020;40(13):1410&#x2013;1421.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7645597</ArticleId><ArticleId IdType="pubmed">33146036</ArticleId></ArticleIdList></Reference><Reference><Citation>Go&#xeb;rtz Y.M.J., Van Herck M., Delbressine J.M. Persistent symptoms 3&#xa0;months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res. 2020;6(4):00542&#x2013;2020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491255</ArticleId><ArticleId IdType="pubmed">33257910</ArticleId></ArticleIdList></Reference><Reference><Citation>Poyraz B.C., Poyraz C.A., Olgun Y. Psychiatric morbidity and protracted symptoms after COVID-19. Psychiatry Res. 2020;295:113604.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7695976</ArticleId><ArticleId IdType="pubmed">33296818</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakusic A., Rabinstein A.A. Cognitive outcomes after critical illness. Curr Opin Crit Care. 2018;24(5):410&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">30036191</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A., Sehgal K., Gupta A. Postacute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka M.T., Carson M.J., El Khoury J. Neuroinflammation in Alzheimer's disease. Lancet Neurol. 2015;14(4):388&#x2013;405.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5909703</ArticleId><ArticleId IdType="pubmed">25792098</ArticleId></ArticleIdList></Reference><Reference><Citation>Barrantes F.J. Central nervous system targets and routes for SARS-CoV-2: current views and new hypotheses. ACS Chem Neurosci. 2020;11(18):2793&#x2013;2803.</Citation><ArticleIdList><ArticleId IdType="pubmed">32845609</ArticleId></ArticleIdList></Reference><Reference><Citation>Lukiw W.J., Pogue A., Hill J.M. SARS-CoV-2 infectivity and neurological targets in the brain. Cell Mol Neurobiol. Published online August 25, 2020 doi: 10.1007/s10571-020-00947-71-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10571-020-00947-71-8</ArticleId><ArticleId IdType="pmc">PMC7445393</ArticleId><ArticleId IdType="pubmed">32840758</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo T., Zhang D., Zeng Y., Huang T.Y., Xu H., Zhao Y. Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer&#x2019;s disease. Mol Neurodegener. 2020;15(1):40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7364557</ArticleId><ArticleId IdType="pubmed">32677986</ArticleId></ArticleIdList></Reference><Reference><Citation>Ansari K.A., Johnson A. Olfactory function in patients with Parkinson's disease. J&#xa0;Chronic Dis. 1975;28(9):493&#x2013;497.</Citation><ArticleIdList><ArticleId IdType="pubmed">1176578</ArticleId></ArticleIdList></Reference><Reference><Citation>Raahimi M.M., Kane A., Moore C.E., Alareed A.W. Late onset of Guillain-Barr&#xe9; syndrome following SARS-CoV-2 infection: part of &#x201c;long COVID-19 syndrome&#x201d;? BMJ Case Rep. 2021;14(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7813388</ArticleId><ArticleId IdType="pubmed">33462068</ArticleId></ArticleIdList></Reference><Reference><Citation>Kempuraj D., Selvakumar G.P., Ahmed M.E. COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. Neuroscientist. 2020;26(5-6):402&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pubmed">32684080</ArticleId></ArticleIdList></Reference><Reference><Citation>Zanin L., Saraceno G., Panciani P.P. SARS-CoV-2 can induce brain and spine demyelinating lesions. Acta Neurochir (Wien) 2020;162(7):1491&#x2013;1494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7197630</ArticleId><ArticleId IdType="pubmed">32367205</ArticleId></ArticleIdList></Reference><Reference><Citation>Palao M., Fern&#xe1;ndez-D&#xed;az E., Gracia-Gil J., Romero-S&#xe1;nchez C.M., D&#xed;az-Maroto I., Segura T. Multiple sclerosis following SARS-CoV-2 infection. Mult Scler Relat Disord. 2020;45:102377.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7340057</ArticleId><ArticleId IdType="pubmed">32698095</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza M.G., De Lorenzo R., Conte C. COVID-19 BioB Outpatient Clinic Study Group. Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. 2020;89:594&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: retrospective cohort studies of 62&#x2008;354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8(2):130&#x2013;140.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>Cable N. COVID-19 pandemic: urgent needs to support and monitor long-term effects of mental strain on people. Am J Public Health. 2020;110(11):1595&#x2013;1596.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7542287</ArticleId><ArticleId IdType="pubmed">33026868</ArticleId></ArticleIdList></Reference><Reference><Citation>Hertz-Palmor N., Moore T., Gothelf D. Association among income loss, financial strain and depressive symptoms during COVID-19: evidence from two longitudinal studies. J Affect Disord. 2021;291:1&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8460400</ArticleId><ArticleId IdType="pubmed">34022550</ArticleId></ArticleIdList></Reference><Reference><Citation>Shanahan L., Steinhoff A., Bechtiger L. Emotional distress in young adults during the COVID-19 pandemic: evidence of risk and resilience from a longitudinal cohort study. Psychol Med. Published online June 23, 2020 doi: 10.1017/S003329172000241X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S003329172000241X</ArticleId><ArticleId IdType="pmc">PMC7338432</ArticleId><ArticleId IdType="pubmed">32571438</ArticleId></ArticleIdList></Reference><Reference><Citation>O'Connor R.C., Wetherall K., Cleare S. Mental health and well-being during the COVID-19 pandemic: longitudinal analyses of adults in the UK COVID-19 Mental Health &amp; Wellbeing study. Br J Psychiatry. Published October 21, 2020 doi:v10.1192/bjp.2020,212.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7684009</ArticleId><ArticleId IdType="pubmed">33081860</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce M., Hope H., Ford T. Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population. Lancet Psychiatry. 2020;7(10):883&#x2013;892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7373389</ArticleId><ArticleId IdType="pubmed">32707037</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikuchi H., Machida M., Nakamura I. Changes in psychological distress during the COVID-19 pandemic in Japan: a longitudinal study. J&#xa0;Epidemiol. 2020;30(11):522&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7557175</ArticleId><ArticleId IdType="pubmed">32963212</ArticleId></ArticleIdList></Reference><Reference><Citation>Holingue C., Kalb L.G., Riehm K.E. Mental distress in the United States at the beginning of the COVID-19 pandemic. Am J Public Health. 2020;110(11):1628&#x2013;1634.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7542294</ArticleId><ArticleId IdType="pubmed">32941066</ArticleId></ArticleIdList></Reference><Reference><Citation>Galea S., Abdalla S.M. COVID-19 pandemic, unemployment, and civil unrest: underlying deep racial and socioeconomic divides. JAMA. 2020;324(3):227&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">32530457</ArticleId></ArticleIdList></Reference><Reference><Citation>Fowers A, Wan W. Depression and anxiety spiked among black Americans after George Floyd&#x2019;s death. Washington Post. June 12, 2020. Accessed May 1, 2021. https://www.washingtonpost.com/health/2020/06/12/mental-health-george-floyd-census/</Citation></Reference><Reference><Citation>Kessler R.C., Rose S., Koenen K.C. How well can post-traumatic stress disorder be predicted from pre-trauma risk factors? An exploratory study in the WHO World Mental Health Surveys. World Psychiatry. 2014;13:265&#x2013;274.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4219068</ArticleId><ArticleId IdType="pubmed">25273300</ArticleId></ArticleIdList></Reference><Reference><Citation>Forneris C.A., Gartlehner G., Brownley K.A. Interventions to prevent post-traumatic stress disorder: a systematic review. Am J Prev Med. 2013;44(6):635&#x2013;650.</Citation><ArticleIdList><ArticleId IdType="pubmed">23683982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hou W.K., Lee T.M., Liang L. Civil unrest, COVID-19 stressors, anxiety, and depression in the acute phase of the pandemic: a population-based study in Hong Kong. Soc Psychiatry Psychiatr Epidemiol. Published online February 16, 2021 doi: 10.1007/s00127-021-02037-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00127-021-02037-5</ArticleId><ArticleId IdType="pmc">PMC7884208</ArticleId><ArticleId IdType="pubmed">33590313</ArticleId></ArticleIdList></Reference><Reference><Citation>Weng J., Li Y., Li J. Gastrointestinal sequelae 90&#xa0;days after discharge for COVID-19. Lancet Gastroenterol Hepatol. 2021;6(5):344&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7943402</ArticleId><ArticleId IdType="pubmed">33711290</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K.S., Hung I.F.N., Chan P.P.Y. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159(1):81&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y., Guo C., Tang L. Prolonged presence of SARS-CoV-2 viral RNA in faecal samples. Lancet Gastroenterol Hepatol. 2020;5(5):434&#x2013;435.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7158584</ArticleId><ArticleId IdType="pubmed">32199469</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944&#x2013;955.e8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Donati Zeppa S., Agostini D., Piccoli G., Stocchi V., Sestili P. Gut microbiota status in COVID-19: an unrecognized player? Front Cell Infect Microbiol. 2020;10:576551.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725702</ArticleId><ArticleId IdType="pubmed">33324572</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang X., Yu Y., Xu J. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020;8(5):475&#x2013;481.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102538</ArticleId><ArticleId IdType="pubmed">32105632</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen T., Wu D., Chen H. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190011</ArticleId><ArticleId IdType="pubmed">32217556</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirsch J.S., Ng J.H., Ross D.W., Northwell COVID-19 Research Consortium. Northwell Nephrology COVID-19 Research Consortium Acute kidney injury in patients hospitalized with COVID-19. Kidney Int. 2020;98(1):209&#x2013;218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7229463</ArticleId><ArticleId IdType="pubmed">32416116</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens J.S., King K.L., Robbins-Juarez S.Y. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy. PLoS One. 2021;15(12)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7769434</ArticleId><ArticleId IdType="pubmed">33370368</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilbers T.J., Koning M.V. Renal replacement therapy in critically ill patients with COVID-19: a retrospective study investigating mortality, renal recovery and filter lifetime. J&#xa0;Crit Care. 2020;60:103&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7391167</ArticleId><ArticleId IdType="pubmed">32795841</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowe B., Cai M., Xie Y., Gibson A.K., Maddukuri G., Al-Aly Z. Acute kidney injury in a national cohort of hospitalized US veterans with COVID-19. Clin J Am Soc Nephrol. 2020;16(1):14&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7792643</ArticleId><ArticleId IdType="pubmed">33199414</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Coca S.G., Chan L., STOP-COVID Investigators AKI treated with renal replacement therapy in critically ill patients with COVID-19. J&#xa0;Am Soc Nephrol. 2021;32(1):161&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7894677</ArticleId><ArticleId IdType="pubmed">33067383</ArticleId></ArticleIdList></Reference><Reference><Citation>Hartmann-Boyce J., Morris E., Goyder C. Diabetes and COVID-19: risks, management, and learnings from other national disasters. Diabetes Care. 2020;43(8):1695&#x2013;1703.</Citation><ArticleIdList><ArticleId IdType="pubmed">32546593</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubino F., Amiel S.A., Zimmet P. New-onset diabetes in Covid-19. N&#xa0;Engl J Med. 2020;383(8):789&#x2013;790.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7304415</ArticleId><ArticleId IdType="pubmed">32530585</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.K., Lin S.S., Ji X.J., Guo L.M. Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol. 2010;47:193&#x2013;199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7088164</ArticleId><ArticleId IdType="pubmed">19333547</ArticleId></ArticleIdList></Reference><Reference><Citation>Aabdi M., Aarab A., Es-Saad O., Malki K., Bkiyar H., Housni B. New-onset diabetes in children during COVID-19: clinical case report. Case Rep Endocrinol. 2021;2021:6654019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7879331</ArticleId><ArticleId IdType="pubmed">33628531</ArticleId></ArticleIdList></Reference><Reference><Citation>Nassar M., Nso N., Baraka B. The association between COVID-19 and type 1 diabetes mellitus: a systematic review. Diabetes Metab Syndr. 2021;15(1):447&#x2013;454.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7872855</ArticleId><ArticleId IdType="pubmed">33592371</ArticleId></ArticleIdList></Reference><Reference><Citation>Cariou B., Pichelin M., Goronflot T., CORONADO Investigators Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: results from the CORONADO study. Diabetes Res Clin Pract. 2021;175:108695.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7872857</ArticleId><ArticleId IdType="pubmed">33577905</ArticleId></ArticleIdList></Reference><Reference><Citation>Alsadhan I., Alruwashid S., Alhamad M. Diabetic ketoacidosis precipitated by coronavirus disease 2019 infection: case series. Curr Ther Res Clin Exp. 2020;93:100609.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7590633</ArticleId><ArticleId IdType="pubmed">33132404</ArticleId></ArticleIdList></Reference><Reference><Citation>Chee Y.J., Ng S.J.H., Yeoh E. Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus. Diabetes Res Clin Pract. 2020;164:108166.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194589</ArticleId><ArticleId IdType="pubmed">32339533</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Wang X., Chen J., Zuo X., Zhang H., Deng A. COVID-19 infection may cause ketosis and ketoacidosis. Diabetes Obes Metab. 2020;22(10):1935&#x2013;1941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264681</ArticleId><ArticleId IdType="pubmed">32314455</ArticleId></ArticleIdList></Reference><Reference><Citation>Siddiqui R.S., Zirkiyeva M., Saliaj M. Onset of ketosis-prone diabetes in the setting of COVID-19 infection. Cureus. 2020;12(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7606204</ArticleId><ArticleId IdType="pubmed">33154847</ArticleId></ArticleIdList></Reference><Reference><Citation>Pasquel F.J., Messler J., Booth R. Characteristics of and mortality associated with diabetic ketoacidosis among US patients hospitalized with or without COVID-19. JAMA Netw Open. 2021;4(3)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948057</ArticleId><ArticleId IdType="pubmed">33688962</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J.K., Feng Y., Yuan M.Y. Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med. 2006;23(6):623&#x2013;628.</Citation><ArticleIdList><ArticleId IdType="pubmed">16759303</ArticleId></ArticleIdList></Reference><Reference><Citation>Orford N.R., Bailey M., Bellomo R. The association of time and medications with changes in bone mineral density in the 2 years after critical illness. Crit Care. 2017;21(1):69.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5361814</ArticleId><ArticleId IdType="pubmed">28327171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirwan R., McCullough D., Butler T., Perez de Heredia F., Davies I.G., Stewart C. Sarcopenia during COVID-19 lockdown restrictions: long-term health effects of short-term muscle loss. Geroscience. 2020;42(6):1547&#x2013;1578.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7528158</ArticleId><ArticleId IdType="pubmed">33001410</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS One. 2020;15(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizrahi B., Shilo S., Rossman H. Longitudinal symptom dynamics of COVID-19 infection. Nat Commun. 2020;11(1):6208.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7718370</ArticleId><ArticleId IdType="pubmed">33277494</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson J.F. Case report and systematic review suggest that children may experience similar long-term effects to adults after clinical&#xa0;COVID-19. Acta Paediatr. 2021;110(3):914&#x2013;921.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7753397</ArticleId><ArticleId IdType="pubmed">33205450</ArticleId></ArticleIdList></Reference><Reference><Citation>Perrin R., Riste L., Hann M., Walther A., Mukherjee A., Heald A. Into the looking glass: post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7320866</ArticleId><ArticleId IdType="pubmed">32758891</ArticleId></ArticleIdList></Reference><Reference><Citation>Wostyn P. COVID-19 and chronic fatigue syndrome: is the worst yet to come? Med Hypotheses. 2021;146:110469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836544</ArticleId><ArticleId IdType="pubmed">33401106</ArticleId></ArticleIdList></Reference><Reference><Citation>Komaroff A.L., Bateman L. Will COVID-19 lead to myalgic encephalomyelitis/chronic fatigue syndrome? Front Med (Lausanne) 2021;7:606824.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7848220</ArticleId><ArticleId IdType="pubmed">33537329</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirza F.N., Malik A.A., Omer S.B., Sethi A. Dermatologic manifestations of COVID-19: a comprehensive systematic review. Int J Dermatol. 2021;60(4):418&#x2013;450.</Citation><ArticleIdList><ArticleId IdType="pubmed">33141443</ArticleId></ArticleIdList></Reference><Reference><Citation>McMahon D.E., Gallman A.E., Hruza G.J. Long COVID in the skin: a registry analysis of COVID-19 dermatological duration. Lancet Infect Dis. 2021;21(3):313&#x2013;314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7836995</ArticleId><ArticleId IdType="pubmed">33460566</ArticleId></ArticleIdList></Reference><Reference><Citation>Buonsenso D., Munblit D., De Rose C. Preliminary evidence on long COVID in children. Acta Paediatr. 2021;110(7):2208&#x2013;2211.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8251440</ArticleId><ArticleId IdType="pubmed">33835507</ArticleId></ArticleIdList></Reference><Reference><Citation>Galeotti C., Bayry J. Autoimmune and inflammatory diseases following COVID-19. Nat Rev Rheumatol. 2020;16(8):413&#x2013;414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7271827</ArticleId><ArticleId IdType="pubmed">32499548</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdoni L., Mazza A., Gervasoni A. An outbreak of severe Kawasaki-like disease at the Italian epicentre of the SARS-CoV-2 epidemic: an observational cohort study. Lancet. 2020;395(10239):1771&#x2013;1778.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7220177</ArticleId><ArticleId IdType="pubmed">32410760</ArticleId></ArticleIdList></Reference><Reference><Citation>Belhadjer Z., M&#xe9;ot M., Bajolle F. Acute heart failure in multisystem inflammatory syndrome in children in the context of global SARS-CoV-2 pandemic. Circulation. 2020;142(5):429&#x2013;436.</Citation><ArticleIdList><ArticleId IdType="pubmed">32418446</ArticleId></ArticleIdList></Reference><Reference><Citation>Riphagen S., Gomez X., Gonzalez-Martinez C., Wilkinson N., Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. Lancet. 2020;395(10237):1607&#x2013;1608.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7204765</ArticleId><ArticleId IdType="pubmed">32386565</ArticleId></ArticleIdList></Reference><Reference><Citation>Almoosa Z.A., Al Ameer H.H., AlKadhem S.M., Busaleh F., AlMuhanna F.A., Kattih O. Multisystem inflammatory syndrome in children, the real disease of COVID-19 in pediatrics: a multicenter case series from Al-Ahsa, Saudi Arabia. Cureus. 2020;12(10)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7682634</ArticleId><ArticleId IdType="pubmed">33240687</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmed M., Advani S., Zoretic S. Multisystem inflammatory syndrome in children: a systematic review. EClinicalMedicine. 2020;26:100527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7473262</ArticleId><ArticleId IdType="pubmed">32923992</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang L., Tang K., Levin M. COVID-19 and multisystem inflammatory syndrome in children and adolescents. Lancet Infect Dis. 2020;20(11):e276&#x2013;e288.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7431129</ArticleId><ArticleId IdType="pubmed">32818434</ArticleId></ArticleIdList></Reference><Reference><Citation>Henderson L.A., Canna S.W., Friedman K.G. American College of Rheumatology clinical guidance for multisystem inflammatory syndrome in children associated with SARS-CoV-2 and hyperinflammation in pediatric COVID-19: version 1. Arthritis Rheumatol. 2020;72(11):1791&#x2013;1805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405113</ArticleId><ArticleId IdType="pubmed">32705809</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D.T., Hamilton F.W., Milne A. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2021;76(4):399&#x2013;401.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Khunti K., Nafilyan V. Post-covid syndrome in individuals admitted to hospital with covid-19: retrospective cohort study. BMJ. 2021;372:n693.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010267</ArticleId><ArticleId IdType="pubmed">33789877</ArticleId></ArticleIdList></Reference><Reference><Citation>Adegunsoye A., Ventura I.B., Liarski V.M. Association of Black race with outcomes in COVID-19 disease: a retrospective cohort study. Ann Am Thorac Soc. 2020;17(10):1336&#x2013;1339.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7640625</ArticleId><ArticleId IdType="pubmed">32643398</ArticleId></ArticleIdList></Reference><Reference><Citation>Bandi S., Nevid M.Z., Mahdavinia M. African American children are at higher risk of COVID-19 infection. Pediatr Allergy Immunol. 2020;31(7):861&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283894</ArticleId><ArticleId IdType="pubmed">32469426</ArticleId></ArticleIdList></Reference><Reference><Citation>Jehi L., Ji X., Milinovich A. Individualizing risk prediction for positive coronavirus disease 2019 testing: results from 11,672 patients. Chest. 2020;158(4):1364&#x2013;1375.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286244</ArticleId><ArticleId IdType="pubmed">32533957</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez D.A., Hinson J.S., Klein E.Y. SARS-CoV-2 positivity rate for Latinos in the Baltimore&#x2013;Washington, DC region. JAMA. 2020;324(4):392&#x2013;395.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7303900</ArticleId><ArticleId IdType="pubmed">32556212</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes D.M., Oliveira C.R., Guerguis S. Tri-State Pediatric COVID-19 Research Consortium. Severe acute respiratory syndrome coronavirus 2 clinical syndromes and predictors of disease severity in hospitalized children and youth. J&#xa0;Pediatr. 2021;230:23&#x2013;31.e10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666535</ArticleId><ArticleId IdType="pubmed">33197493</ArticleId></ArticleIdList></Reference><Reference><Citation>Zalla L.C., Martin C.L., Edwards J.K., Gartner D.R., Noppert G.A. A&#xa0;geography of risk: structural racism and COVID-19 mortality in the United States. Am J Epidemiol. 2021;190:1439&#x2013;1446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7989642</ArticleId><ArticleId IdType="pubmed">33710272</ArticleId></ArticleIdList></Reference><Reference><Citation>Katikireddi S.V., Lal S., Carrol E.D. Unequal impact of the COVID-19 crisis on minority ethnic groups: a framework for understanding and addressing inequalities. J&#xa0;Epidemiol Community Health. 2021;75:970&#x2013;974.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8458062</ArticleId><ArticleId IdType="pubmed">33883198</ArticleId></ArticleIdList></Reference><Reference><Citation>Millett G.A., Jones A.T., Benkeser D. Assessing differential impacts of COVID-19 on Black communities. Ann Epidemiol. 2020;47:37&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7224670</ArticleId><ArticleId IdType="pubmed">32419766</ArticleId></ArticleIdList></Reference><Reference><Citation>Lewis N.M., Friedrich M., Wagstaff S. Disparities in COVID-19 incidence, hospitalizations, and testing, by area-level deprivation&#x2014;Utah, March 3&#x2013;July 9, 2020. MMWR Morb Mortality Wkly Rep. 2020;69(38):1369&#x2013;1373.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727491</ArticleId><ArticleId IdType="pubmed">32970656</ArticleId></ArticleIdList></Reference><Reference><Citation>Karaye I.M., Horney J.A. The impact of social vulnerability on COVID-19 in the U.S.: an analysis of spatially varying relationships. Am J Prev Med. 2020;59(3):317&#x2013;325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318979</ArticleId><ArticleId IdType="pubmed">32703701</ArticleId></ArticleIdList></Reference><Reference><Citation>Okoh A.K., Sossou C., Dangayach N.S. Coronavirus disease 19 in minority populations of Newark, New Jersey. Int J Equity Health. 2020;19(1):93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7286208</ArticleId><ArticleId IdType="pubmed">32522191</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace M., Hagan L., Curran K.G. COVID-19 in correctional and detention facilities&#x2014;United States, February-April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(19):587&#x2013;590.</Citation><ArticleIdList><ArticleId IdType="pubmed">32407300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallace M., Marlow M., Simonson S. Public health response to COVID-19 cases in correctional and detention facilities&#x2014;Louisiana, March-April 2020. MMWR Morb Mortal Wkly Rep. 2020;69(19):594&#x2013;598.</Citation><ArticleIdList><ArticleId IdType="pubmed">32407301</ArticleId></ArticleIdList></Reference><Reference><Citation>Tobolowsky F.A., Gonzales E., Self J.L. COVID-19 Outbreak among three affiliated homeless service sites&#x2014;King County, Washington, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(17):523&#x2013;526.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7206987</ArticleId><ArticleId IdType="pubmed">32352954</ArticleId></ArticleIdList></Reference><Reference><Citation>McMichael T.M., Clark S., Pogosjans S. COVID-19 in a long-term care facility&#x2014;King County, Washington, February 27-March 9, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(12):339&#x2013;342.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7725515</ArticleId><ArticleId IdType="pubmed">32214083</ArticleId></ArticleIdList></Reference><Reference><Citation>Jim&#xe9;nez M.C., Cowger T.L., Simon L.E., Behn M., Cassarino N., Bassett M.T. Epidemiology of COVID-19 among incarcerated individuals and staff in Massachusetts jails and prisons. JAMA Netw Open. 2020;3(8)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7442924</ArticleId><ArticleId IdType="pubmed">32821919</ArticleId></ArticleIdList></Reference><Reference><Citation>Henry M, Watt R, Mahathey A, et&#xa0;al; Abt Associates. The 2019 Annual Homeless Assessment Report (AHAR) to Congress. Office of Community Planning and Development. United States Department of Housing and Urban Development. 2020. Accessed May 1, 2021. https://www.huduser.gov/portal/sites/default/files/pdf/2019-AHAR-Part-1.pdf</Citation></Reference><Reference><Citation>Hawkins D. Differential occupational risk for COVID-19 and other infection exposure according to race and ethnicity. Am J Ind Med. 2020;63(9):817&#x2013;820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323065</ArticleId><ArticleId IdType="pubmed">32539166</ArticleId></ArticleIdList></Reference><Reference><Citation>Bui D.P., McCaffrey K., Friedrichs M. Racial and ethnic disparities among COVID-19 cases in workplace outbreaks by industry sector&#x2014;Utah, March 6-June 5, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(33):1133&#x2013;1138.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7439983</ArticleId><ArticleId IdType="pubmed">32817604</ArticleId></ArticleIdList></Reference><Reference><Citation>Waltenburg M.A., Victoroff T., Rose C.E. Update: COVID-19 among workers in meat and poultry processing facilities&#x2014;United States, April-May 2020. MMWR Morb Mortal Wkly Rep. 2020;69(27):887&#x2013;892.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732361</ArticleId><ArticleId IdType="pubmed">32644986</ArticleId></ArticleIdList></Reference><Reference><Citation>Selden T.M., Berdahl T.A. COVID-19 and racial/ethnic disparities in health risk, employment, and household composition. Health Aff (Millwood) 2020;39(9):1624&#x2013;1632.</Citation><ArticleIdList><ArticleId IdType="pubmed">32663045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsu H.E., Ashe E.M., Silverstein M. Race/ethnicity, underlying medical conditions, homelessness, and hospitalization status of adult patients with COVID-19 at an urban safety-net medical center&#x2014;Boston, Massachusetts, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(27):864&#x2013;869.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7727597</ArticleId><ArticleId IdType="pubmed">32644981</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis J., Penha J., Mbowe O., Taira D.A. Prevalence of single and multiple leading causes of death by race/ethnicity among US adults aged 60 to 79 years. Prev Chronic Dis. 2017;14:E101.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5652239</ArticleId><ArticleId IdType="pubmed">29049018</ArticleId></ArticleIdList></Reference><Reference><Citation>Care Without Coverage: Too Little, Too Late. The National Academies Press; 2002.</Citation><ArticleIdList><ArticleId IdType="pubmed">25057604</ArticleId></ArticleIdList></Reference><Reference><Citation>Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. The National Academies Press; 2003.</Citation><ArticleIdList><ArticleId IdType="pubmed">25032386</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Q., Jackson S., Derakhshan S. Urban-rural differences in COVID-19 exposures and outcomes in the South: a preliminary analysis of South Carolina. PLoS One. 2021;16(2)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857563</ArticleId><ArticleId IdType="pubmed">33534870</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 stats: COVID-19 incidence, by urban-rural classification&#x2014;United States, January 22-October 31, 2020. MMWR Morb Mortal Wkly Rep. 2020;69(46):1753.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7676636</ArticleId><ArticleId IdType="pubmed">33211682</ArticleId></ArticleIdList></Reference><Reference><Citation>Gigliotti P., Martin E.G. Predictors of state-level stay-at-home orders in the United States and their association with mobility of residents. J&#xa0;Public Health Manag Pract. 2020;26(6):622&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">32969952</ArticleId></ArticleIdList></Reference><Reference><Citation>Greiner B., Ottwell R., Vassar M., Hartwell M. Public interest in preventive measures of coronavirus disease 2019 associated with timely issuance of statewide stay-at-home orders. Disaster Med Public Health Prep. 2020;14(6):765&#x2013;768.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306550</ArticleId><ArticleId IdType="pubmed">32498752</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman G., Kim S., Rexer J.M., Thirumurthy H. Political partisanship influences behavioral responses to governors' recommendations for COVID-19 prevention in the United States. Proc Natl Acad Sci U S A. 2020;117(39):24144&#x2013;24153.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7533884</ArticleId><ArticleId IdType="pubmed">32934147</ArticleId></ArticleIdList></Reference><Reference><Citation>Solis J., Franco-Paredes C., Henao-Mart&#xed;nez A.F., Krsak M., Zimmer S.M. Structural vulnerability in the U.S. revealed in three waves of COVID-19. Am J Trop Med Hyg. 2020;103(1):25&#x2013;27.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7263522</ArticleId><ArticleId IdType="pubmed">32383432</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobis E., McGranahan D. Rural residents appear to be more vulnerable to serious infection or death from coronavirus COVID-19. Amber Waves. Economic Research Service. U.S. Department of Agriculture; February 1, 2021. https://www.ers.usda.gov/amber-waves/2021/february/rural-residents-appear-to-be-more-vulnerable-to-serious-infection-or-death-from-coronavirus-covid-19/ Accessed May 1, 2021.</Citation></Reference><Reference><Citation>Peters D.J. Community susceptibility and resiliency to COVID-19 across the rural-urban continuum in the United States. J&#xa0;Rural Health. 2020;36(3):446&#x2013;456.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323251</ArticleId><ArticleId IdType="pubmed">32543751</ArticleId></ArticleIdList></Reference><Reference><Citation>Henning-Smith C. The unique impact of COVID-19 on older adults in rural areas. J&#xa0;Aging Soc Policy. 2020;32(4-5):396&#x2013;402.</Citation><ArticleIdList><ArticleId IdType="pubmed">32475255</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoar S., Khavandi S., Tabibzadeh E. A&#xa0;late COVID-19 complication: male sexual dysfunction. Prehosp Disaster Med. 2020;35(6):688&#x2013;689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7545238</ArticleId><ArticleId IdType="pubmed">32959752</ArticleId></ArticleIdList></Reference><Reference><Citation>Kresch E., Achua J., Saltzman R. COVID-19 endothelial dysfunction can cause erectile dysfunction: histopathological, immunohistochemical, and ultrastructural study of the human penis. World J Mens Health. 2021;39(3):466&#x2013;469.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8255400</ArticleId><ArticleId IdType="pubmed">33988001</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwal S., Agarwal S.K. Endocrine changes in SARS-CoV-2 patients and lessons from SARS-CoV. Postgrad Med J. 2020;96(1137):412&#x2013;416.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7306278</ArticleId><ArticleId IdType="pubmed">32527756</ArticleId></ArticleIdList></Reference><Reference><Citation>Leow M.K.-S., Kwek D.S.-K., Ng A.W.-K., Ong K.-C., Kaw G.J.-L., Lee L.S.-U. Hypocortisolism in survivors of severe acute respiratory syndrome (SARS) Clin Endocrinol (Oxf) 2005;63(2):197&#x2013;202.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188349</ArticleId><ArticleId IdType="pubmed">16060914</ArticleId></ArticleIdList></Reference><Reference><Citation>Austin J. Mayo Clinic's COVID-19 &#x201c;rehab&#x201d; program helps patients with long-lasting symptoms. KARE11; 2021. Accessed May 1, 2021. https://www.kare11.com/article/news/health/coronavirus/covid-long-hauler-mayo-clinic-rehab-program-rochester/89-86a7f6ad-b8d7-4a20-bd96-b8b0ec76f49f</Citation></Reference><Reference><Citation>Novak S. &#x201c;Long COVID&#x201d; can last months. New St. Luke&#x2019;s clinic will aid &#x201c;long-hauler&#x201d; recovery. Advance Local Media; 2021. Accessed May 1, 2021. https://www.lehighvalleylive.com/coronavirus/2021/04/long-covid-can-last-months-new-st-lukes-clinic-will-aid-long-hauler-recovery.html</Citation></Reference><Reference><Citation>Reed J. Inside a long Covid clinic: &#x201c;I want to play with my kids again.&#x201d; BBC; 2021. Accessed May 1, 2021. https://www.bbc.com/news/health-56879203</Citation></Reference><Reference><Citation>Mattison S. Post-COVID clinic on Oahu has helped dozens of long haul patients. KHON; 2021. Accessed May 1, 2021. https://www.khon2.com/coronavirus/post-covid-clinic-on-oahu-has-helped-dozens-of-long-haul-patients/</Citation></Reference><Reference><Citation>Hurley B. Clinics, treatments for COVID-19 long haulers to be offered soon in the Valley. Valley News Live; 2021. Accessed May 1, 2021. https://www.valleynewslive.com/2021/04/22/clinics-treatments-for-covid-9-long-haulers-to-be-offered-soon-in-the-valley/</Citation></Reference><Reference><Citation>Riemer E. Specialized Boston clinics treat long-haul COVID-19 patients. WCVB; 2021. Accessed May 1, 2021. https://www.wcvb.com/article/specialized-boston-clinics-treat-long-haul-covid-19-patients/36027344</Citation></Reference><Reference><Citation>Carbajal E. 33 hospitals, health systems that have launched post-COVID-19 clinics. Becker&#x2019;s Hospital Review. Becker&#x2019;s Healthcare, 2021. Accessed May 1, 2021. https://www.beckershospitalreview.com/patient-safety-outcomes/13-hospitals-health-systems-that-have-launched-post-covid-19-clinics.html</Citation></Reference><Reference><Citation>Berger Z., Altiery D.E.J.V., Assoumou S.A., Greenhalgh T. Long COVID and health inequities: the role of primary care. Milbank Q. 2021;99(2):519&#x2013;541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8241274</ArticleId><ArticleId IdType="pubmed">33783907</ArticleId></ArticleIdList></Reference><Reference><Citation>Raj S.R., Arnold A.C., Barboi A. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021;31(3):365&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7976723</ArticleId><ArticleId IdType="pubmed">33740207</ArticleId></ArticleIdList></Reference><Reference><Citation>Post COVID/long COVID. COVID-19 Real-Time Learning Network. Infectious Diseases Society of America; 2021. Accessed May 1, 2021. https://www.idsociety.org/covid-19-real-time-learning-network/disease-manifestations--complications/post-covid-syndrome/</Citation></Reference><Reference><Citation>Parkin A., Davison J., Tarrant R. A&#xa0;multidisciplinary NHS COVID-19 service to manage post-COVID-19 syndrome in the community. J&#xa0;Prim Care Community Health. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8064663</ArticleId><ArticleId IdType="pubmed">33880955</ArticleId></ArticleIdList></Reference><Reference><Citation>George P.M., Barratt S., Desai S.R. British Thoracic Society; 2020. British Thoracic Society Guidance on Respiratory Follow Up of Patients with a Clinico-Radiological Diagnosis of COVID-19 Pneumonia.</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence . National Institute for Health and Care Excellence; 2020. Clinical Guidelines. COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold D., Milne A., Samms E., Stadon L., Maskell N., Hamilton F. Are vaccines safe in patients with Long COVID? A prospective observational study. Preprint. Posted online March 14, 2021. medRxiv. 2021 doi: 10.1101/2021.03.11.21253225.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.11.21253225</ArticleId></ArticleIdList></Reference><Reference><Citation>Guarino B. Some long-haul covid-19 patients say their symptoms are subsiding after getting vaccines. Washington Post; 2021. Accessed May 1, 2021. https://www.washingtonpost.com/health/long-haul-covid-vaccine/2021/03/16/6effcb28-859e-11eb-82bc-e58213caa38e_story.html</Citation></Reference><Reference><Citation>COVID-19 vaccinations in the United States. COVID Data Tracker. Centers for Disease Control&#xa0;and Prevention; 2021. Accessed May 1, 2021. https://covid.cdc.gov/covid-data-tracker/#datatracker-home</Citation></Reference><Reference><Citation>Razai M.S., Osama T., McKechnie D.G.J., Majeed A. Covid-19 vaccine hesitancy among ethnic minority groups. BMJ. 2021;372:n513.</Citation><ArticleIdList><ArticleId IdType="pubmed">33637577</ArticleId></ArticleIdList></Reference><Reference><Citation>MacKenna B., Curtis H.J., Morton C.E. Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY. Preprint. Posted online January 26, 2021. medRxiv. 2021 doi: 10.1101/2021.01.25.21250356.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.01.25.21250356</ArticleId></ArticleIdList></Reference><Reference><Citation>Khan M.S., Ali S.A.M., Adelaine A., Karan A. Rethinking vaccine hesitancy among minority groups. Lancet. 2021;397(10288):1863&#x2013;1865.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8059987</ArticleId><ArticleId IdType="pubmed">33894143</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang D.H., McCoy R.G. Planning for the post-COVID syndrome: how payers can mitigate&#xa0;long-term complications of the pandemic. J&#xa0;Gen Intern Med. 2020;35(10):3036&#x2013;3039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7375754</ArticleId><ArticleId IdType="pubmed">32700223</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D., Wirtheim E., Vetter P. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020;20(10):1115&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>